Scientists Give Star Treatment to Lesser-Known Cells Crucial for Brain Development
• Press Release
After decades of relative neglect, star-shaped brain cells called astrocytes are finally getting their due. To gather insight into a critical aspect of brain development, a team of scientists examined the maturation of astrocytes in 3-D structures grown in culture dishes to resemble human brain tissue. The study, which confirms that the lab-grown cells develop at the same rate as those found in human brains, was published in Neuron, August 16, 2017.
It was funded in part by the National Institutes of Health’s National Institute of Neurological Disorders and Stroke (NINDS), National Institute of Mental Health (NIMH), National Institute of General Medical Sciences (NIGMS) and National Center for Advancing Translational Sciences (NCATS).
“This work addresses a significant gap in human brain research by providing an invaluable technique to investigate the role of astrocytes in both normal development and disease,” said NINDS program director Jill Morris, Ph.D.
In 2015, a team directed by Sergiu Pasca, M.D., an assistant professor of psychiatry and behavioral science at Stanford University in California, and Ben Barres, M.D., Ph.D., a Stanford professor of neurobiology, published a method for taking adult skin cells, converting them to induced pluripotent stem cells (iPSCs), and then growing them as 3-D clusters of brain cells called human cortical spheroids (hCSs). These hCSs, which closely resemble miniature versions of a particular brain region, can be grown for many months. The cells in the cluster eventually develop into neurons, astrocytes, and other cells found in the human brain.
“One of the challenges of studying the human brain is the difficulty of examining it at different stages of development,” Dr. Pasca said. “This is a system that tries to simulate brain development step by step.”
In the new study, Steven Sloan, a student in Stanford’s M.D./Ph.D. program, led a series of experiments comparing astrocytes from hCSs to those found in tissue from the developing and adult human brain. The team grew the hCSs for 20 months, one of the longest-ever studies of lab-grown human brain cells.
The results verified that the lab-grown cells change over time in a similar manner to cells taken directly from brain tissue during very early life, a critical time for brain growth. This process is considered critical for normal brain development and deviations are thought to cause a variety of neurological and mental health disorders, such as schizophrenia and autism. Creating hCSs using cells from patients could allow scientists to uncover the underlying developmental biology at the core of these disorders.
“The hCS system makes it possible to replay astrocyte development from any patient,” Dr. Barres said. “That’s huge. There’s no other way one could ever do that without this method.”
The current study showed that hCS-grown astrocytes develop at the same rate as those found in human brains, in terms of their gene activity, their shapes, and their functions. For example, astrocytes taken from hCSs that were less than six months old multiplied rapidly and were highly engaged in eliminating unnecessary connections between neurons, just like astrocytes in babies growing in the womb. But astrocytes grown in hCSs for more than nine months could not reproduce and removed significantly fewer of those connections, mirroring astrocytes in infants 6 to 12 months old. On the other hand, just like astrocytes from developing and adult brains, the early- and late-stage astrocytes from hCSs were equally effective at encouraging new connections to form between neurons.
“Astrocytes are not just bystanders in the brain,” Dr. Pasca said. “They’re not just there to keep neurons warm; they actually participate actively in neurological function.”
“Since astrocytes make up a greater proportion of brain cells in humans than in other species, it may reflect a greater need for astrocytes in normal human brain function, with more significant consequences when they don’t work correctly,” added NIMH program director David Panchision, Ph.D.
The researchers caution that hCSs are only a model and lack many features of real brains. Moreover, certain genes that are active in fully mature astrocytes never switched on in the hCS-grown astrocytes, which they could conceivably do if the cells had more time to develop. To address this question, the researchers now hope to identify ways to produce mature brain cells more quickly. hCSs could also be used to scrutinize precisely what causes astrocytes to change over time and to screen drugs that might correct any differences that occur in brain disease.
“These are questions that are going to be very exciting to explore,” Dr. Barres said.
The study was funded by NINDS (NS081703), the National Institute of Mental Health (MH099555, MH107800, MH106261), the National Institute of General Medical Sciences (GM007365), the National Center for Advancing Translational Sciences (TR001085), the California Institute of Regenerative Medicine, the MQ Fellow Award, and Stanford University.
Researchers investigate star-shaped brain cells: NIH-funded researchers used 3-D collections of brain tissue grown from human cells to study the brain’s star-shaped astrocytes.
Source: Sergiu Pasca, M.D., Stanford University.
Human Astrocyte Maturation Captured in 3D Cerebral Cortical Spheroids Derived from Pluripotent Stem Cells. Sloan SA, Darmanis S, Huber N, Khan TA, Birey F, Caneda C, Reimer R, Quake SR, Barres BA, Paşca SP. Neuron. 2017 Aug 16;95(4):779-790.e6. doi: 10.1016/j.neuron.2017.07.035. PMID: 28817799
The NINDS is the nation’s leading funder of research on the brain and nervous system. The mission of NINDS is to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease.
About the National Institute of Mental Health (NIMH): The mission of the NIMH is to transform the understanding and treatment of mental illnesses through basic and clinical research, paving the way for prevention, recovery and cure. For more information, visit the NIMH website.
NIGMS is a part of the National Institutes of Health that supports basic research to increase our understanding of biological processes and lay the foundation for advances in disease diagnosis, treatment, and prevention. For more information on the Institute's research and training programs, visit www.nigms.nih.gov.
About the National Center for Advancing Translational Sciences: NCATS is a distinctly different entity in the research ecosystem. Rather than targeting a particular disease or fundamental science, NCATS focuses on what is common across diseases and the translational process. The Center emphasizes innovation and deliverables, relying on the power of data and new technologies to develop, demonstrate and disseminate improvements in translational science that bring about tangible improvements in human health. For more information, visit https://ncats.nih.gov.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit the NIH website.
NIH…Turning Discovery Into Health®